ANGO vs VTR · rev $292.5M vs P/E 149, rev $4.92B
AngioDynamics Inc (ANGO) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
ANGO currently screens at market cap $378.5M. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the ANGO and VTR stock pages for the full models.
Not investment advice.